Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail
NCT01302119
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
604
Enrollment
INDUSTRY
Sponsor class
Conditions
Onychomycosis of Toenails
Interventions
DRUG:
AN2690 Topical Solution, 5%
DRUG:
Solution Vehicle
Sponsor
Pfizer